JP2024518377A5 - - Google Patents
Info
- Publication number
- JP2024518377A5 JP2024518377A5 JP2023567900A JP2023567900A JP2024518377A5 JP 2024518377 A5 JP2024518377 A5 JP 2024518377A5 JP 2023567900 A JP2023567900 A JP 2023567900A JP 2023567900 A JP2023567900 A JP 2023567900A JP 2024518377 A5 JP2024518377 A5 JP 2024518377A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- membered ring
- pharmaceutical product
- epilepsy
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21171769.9 | 2021-05-03 | ||
| EP21171769 | 2021-05-03 | ||
| PCT/EP2022/061860 WO2022233877A1 (en) | 2021-05-03 | 2022-05-03 | Treatment of pharmacoresistant epilepsy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024518377A JP2024518377A (ja) | 2024-05-01 |
| JP2024518377A5 true JP2024518377A5 (https=) | 2025-08-07 |
Family
ID=81748253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023567900A Pending JP2024518377A (ja) | 2021-05-03 | 2022-05-03 | 薬剤耐性癲癇の治療 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250186408A1 (https=) |
| EP (1) | EP4333819A1 (https=) |
| JP (1) | JP2024518377A (https=) |
| WO (1) | WO2022233877A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0823001D0 (en) | 2008-12-17 | 2009-01-28 | Syngenta Participations Ag | Thiophene,furan and pyrrole derivatives with plant growth regulating properties |
| KR20140003438A (ko) | 2010-11-15 | 2014-01-09 | 카톨리에케 유니버시테이트 루벤 | 항바이러스성 축합 헤테로사이클릭 화합물 |
| AR086113A1 (es) | 2011-04-30 | 2013-11-20 | Abbott Lab | Isoxazolinas como agentes terapeuticos |
| CN106279015B (zh) | 2016-08-10 | 2019-06-11 | 安徽省化工研究院 | 一种2-氨基磺酰基-n,n-二甲基烟酰胺的制备方法 |
| CN107602361A (zh) | 2017-09-11 | 2018-01-19 | 大连理工大学 | 一种α,β‑不饱和炔酮化合物的制备方法 |
-
2022
- 2022-05-03 EP EP22724118.9A patent/EP4333819A1/en active Pending
- 2022-05-03 US US18/558,423 patent/US20250186408A1/en active Pending
- 2022-05-03 WO PCT/EP2022/061860 patent/WO2022233877A1/en not_active Ceased
- 2022-05-03 JP JP2023567900A patent/JP2024518377A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2497807C2 (ru) | Карбазольные соединения и терапевтические применения соединений | |
| RU2375363C2 (ru) | Пирролотриазиновые производные анилина, полезные в качестве ингибиторов киназы | |
| JP2005538100A5 (https=) | ||
| JP2007519694A5 (https=) | ||
| JPWO2020085493A5 (https=) | ||
| JP2005535586A5 (https=) | ||
| KR930005992A (ko) | 루코트리엔 생합성 억제제 | |
| RU2010126105A (ru) | Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой, и содержащие их противогрибковые средства | |
| JP2007516206A5 (https=) | ||
| JP2005508967A5 (https=) | ||
| EA031030B1 (ru) | Ингибиторы фактора в комплемента на основе производных пиперидинилиндола и их применение | |
| JPH02157258A (ja) | トロンボキサンa↓2拮抗作用を有する化合物 | |
| RU2002115263A (ru) | 5-членные N-гетероциклические соединения, обладающие гипогликемической и гиполипидемической активностью | |
| JP2006524225A5 (https=) | ||
| TW201021798A (en) | Amide acetate derivative having inhibitory activity on endothelial lipase | |
| JP2005508960A5 (https=) | ||
| JP2013532652A5 (https=) | ||
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| JP2021523168A5 (https=) | ||
| AU2008216106C1 (en) | Cancer treatment method | |
| JP2007517007A5 (https=) | ||
| RU2007108863A (ru) | Производные пиразола для лечения состояний, опосредованных активацией рецептора аденозина а2в или а3 | |
| JP2018536678A5 (https=) | ||
| CA2626402A1 (en) | Potassium channel inhibitors | |
| MX2009002905A (es) | Derivados de 3-amino-piridina para el tratamiento de trastornos metabolicos. |